New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financia... (More than 83 percent of TRC patient with...)

HOME >> MEDICINE >> NEWS

New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes

Date:11/21/2008

More than 83 percent of TRC patient with diabetes were adherent to antihypertensive medications compared with 65.4 percent.

More than 80 percent of TRC patients with diabetes were adherent to cholesterol-lowering medications compared with 62.4 percent.

Of patients with diabetes needing to be on a cholesterol medication 76.6 percent of TRC patients were on a cholesterol medication compared with 63 percent.

Separately, Medco also evaluated the over-use of short-acting rescue inhalers for patients with asthma. Using a protocol-driven approach, the percentage of patients obtaining more than the recommended single canister of the rescue inhaler was reduced from 22 percent to 7 percent. This demonstrates the ability of the TRCs to identify and institute protocols to reduce medication waste and, at the same time, improve patient outcomes.

"These results are great news for those treating patients with chronic illness; they show that barriers to adherence, which have been a persistent and difficult problem, can be overcome with the right therapeutic approach," said Klepper. "Patient counseling by specialist pharmacists appears to have a high degree of success in closing many of the gaps in care that need to be eliminated in order to improve clinical outcomes and lower overall health care costs. This was key to establish high levels of transparency and accountability to our clients."

The TRC approach enlists specialist pharmacists guided by nationally recognized protocols in specific chronic diseases, as well as access to integrated data systems that allow them to leverage both pharmacy and medical information to better assess the patient's condition and recommended course of treatment. These specialist pharmacists are uniquely able to provide in-depth counseling to patients to close a range of clinical gaps in care and, when necessary, to inform their
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
2. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
3. Shining light on sciences dark data: New venture ensures a fuller scientific record
4. New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
5. Five Hospitals to Share Patient Data: ICW Connects Regional Medical Centers and University Facility
6. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
7. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
8. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
9. Advanced lung cancer patients see improved, progression-free survival
10. Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures
11. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens

Post Your Comments:

New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financia...(More than 83 percent of TRC patient with...),Health